Pioglitazone promotes survival and preve
โ
Tomonori Aoyama; Kenichi Ikejima; Kazuyoshi Kon; Kyoko Okumura; Kumiko Arai; Sum
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 699 KB
N onalcoholic fatty liver disease (NAFLD) is one of the important manifestations of metabolic syndrome, a clinical entity comprising obesity, hypertension, glucose intolerance, and hyperlipidemia. [1][2][3] NAFLD includes a spectrum of liver pathology ranging from simple steatosis to nonalcoholic st